TRVI - Trevi Therapeutics GAAP EPS of -$0.14 beats by $0.04 August, 11 2022 04:30 PM Trevi Therapeutics Inc. Trevi Therapeutics press release ( NASDAQ: TRVI ): Q2 GAAP EPS of -$0.14 beats by $0.04 . Company had total cash, cash equivalents and marketable securities of $78.9 million. For further details see: Trevi Therapeutics GAAP EPS of -$0.14 beats by $0.04